Shares in ARS Pharmaceuticals were in freefall in pre-market trading this morning as it emerged that the FDA had declined to approve its application for its lead product, aiming to become the first ...

The FDA workshop aims to improve epinephrine access to reduce anaphylaxis-related morbidity and mortality, addressing barriers like fear and stigma. Neffy, a nasal spray epinephrine by ARS ...

An initial dose of 0.3 mg intramuscular (IM) epinephrine was tied to a greater escalation of care than a dose of 0.5 mg in patients with anaphylaxis, a retrospective single-center study found. The ...

ARS Pharmaceuticals' Neffy nasal spray showed 89.2% success in treating anaphylaxis in 545 patients, comparable to epinephrine injections. FDA approved Neffy in 2024 for adults and children over 30 kg ...

If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...

Click the Date Picker content control button in the Controls group. A Date Picker content control will appear in the document. Click the drop-down arrow and select a date from the calendar; if you ...

Please provide your email address to receive an email when new articles are posted on . 44% of children with anaphylaxis received epinephrine before visiting the ED. There was no difference in ...

Epinephrine nasal solutions from BPI Labs and Endo USA should not be used, according to the FDA. Similarities between the packaging for certain intranasal and intravenous epinephrine products may ...

Epinephrine is an essential tool in dental care, playing a critical role in pain management and procedural control. Most commonly, we use it to enhance the duration of local anesthesia, decrease ...

Soon people will be able to subdue a severe allergic reaction with a nasal spray instead of an injection. The hormone epinephrine is the go-to therapy for anaphylaxis, a potentially life-threatening ...

The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including ...